Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

Maintain REDUCE on PSP Projects - In-line performance - HDFC Securities

Posted On: 2020-08-07 23:42:27

Mr. Parikshit D Kandpal, Institutional Research Analyst, HDFC Securities.

We maintain REDUCE on PSP Projects with a target price of Rs 370/sh (10x Mar-22E EPS). As expected, 1QFY21 was a washout with in-line revenue of Rs 1.07bn (6.1% beat). We have maintained our FY21/22E EPS. Further, sites across Gujarat, Karnataka, Rajasthan and UP remain operational. Labour availability has gradually ramped up from ~20-25% levels to ~70-75% across these states. In Maharashtra, which constitutes ~25% the order book, sites remain shut till date. At present, finishing works are progressing well, with more intensive RCC structural works on hold till labour strength returns to normalcy. No change in FY21E/22E estimates.

1QFY21 Highlights: PSP Projects posted revenue/EBIDTA/APAT of Rs 1,069/13/(22) mn vs our estimates of Rs 1007/58/19 mn. Due to revenue de-growth of 65/77% YoY/QoQ, EBITDA margin slumped by 1,268bps to 1.2%. Company does not expect monsoon to impact work on Surat Diamond Bourse project as large part of exterior work is done and is hopeful of finishing it on time with revised timeline of Apr-21 (Dec-20 pre-COVID).

Order book stands at Rs 29.6bn (including Rs 5.7bn SDB project). Bid book stands at Rs 30bn, which comprises parliament building of Rs 9bn, warehouses, Brigade Hyderabad building, Reliance Jamnagar works, etc. Equity raising plans have been shelved off for now as Central Vista project has been delayed, and in the meantime, completion of several large projects led to freeing up of BG limits. Rs 8mn loss was booked on 1 of the 2 residential units in US. Gross debt stood at Rs 0.72bn, with total fund based and non-fund based utilisation at Rs 3.8bn of the total limit of Rs 6.1bn.

Setting up a pre-cast concrete plant: PSP will invest Rs 750mn in FY21 to set up a pre-cast manufacturing facility. The company has acquired land encompassing an area of ~1.4 mn sq ft near Sanand (about Rs ~250mn outgo on land). PSP intends to cater to both captive and third-party precast demand and envisages payback period to be ~5 years. PSP believes that whilst cost of construction under pre-cast is higher by ~10% vis--vis conventional RCC, it leads to gains in terms of quality and shorter completion timelines. Apart from this, the capex run rate will come down as equipment is to be redeployed from projects nearing completion. We believe that private contract designs are largely consultant or client driven and, hence, projects are built in-situ. Scope of pre-cast is limited. Government contracts are standard and with limited pre-cast scope again. Hence, PSP needs to build awareness and client education for use of this technology. Few product from this plant may be used for captive purpose. Large use can be for affordable housing projects under PMAY which PSP has in Maharashtra.

Shares of PSP Projects Ltd was last trading in BSE at Rs.401.9 as compared to the previous close of Rs. 396.65. The total number of shares traded during the day was 461 in over 87 trades.

The stock hit an intraday high of Rs. 405 and intraday low of 394.35. The net turnover during the day was Rs. 184218.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Mazagon Dock IPO fully subscribed on Day 1 - Angel Broking

Pharma - Sector Thematic - Cardiac: the heartbeat of domestic market - HDFC Securities Institutional Research Desk

Walmart-Tata Retail Deal - Mr. Himanshu Nayyar, YES SECURITIES

HDFC Securities Institutional Research Desk: Chemical Conference Report

Lupin - Launch of Fosaprepitant - Angel Broking

Infosys - Key beneficiary of increased IT spending - Angel Broking

Gateway Distriparks - Holding structure simplified; prepared for next phase of growth - ICICI Securities

Visaka Industries - Demand and pricing tailwinds sustain; maintain a compelling BUY - ICICI Securities

GSK Pharmaceuticals - Analyst call highlights - Sep 28, 2020 - ICICI Securities

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019